Facebook
X
LinkedIn
ForwardAdvanced Heart Disease Symposium
Dallas, TX US
February 7, 2026
The Advanced Heart and Lung Disease Symposia will feature two educational tracks focused on enhancing participants' knowledge and equipping them with practical strategies for the latest advancements in the diagnosis and management of heart and lung diseases.
Target Audience
- Physicians - $285
- Physician Assistant - $245
- Nurse Practitioner - $245
- Nurse - $199
- Fellows - $199
- Residents - $199
- Other - $199
Learning Objectives
Upon completion of this activity, the attendee should be able to:
- Describe the current therapy of strategies of heart failure as related to obesity, pregnancy and diabetes.
- Compare new treatments and devices for heart failure management
- Consider outcomes of great debates on controversies in heart failure management
- Integrate into practice the clinical pearls and pitfalls of recognition and management of cardiogenic shock
- Evaluate the data regarding new therapeutics in multiple disciplines within pulmonary medicine, including asthma, obstructive lung disease, interstitial lung disease, and pulmonary hypertension
- Review updates in lung transplantation
- Compare the data on conservative management versus advanced therapeutics including ECMO, transplantation, catheter directed lysis.
- Review the current state of lung nodule evaluation and then apply in practice appropriate novel diagnostic modalities available.
- Review updates on the treatment and management of pulmonary embolism.
- Interpret the emerging modalities in the field of interventional pulmonology for the purpose of providing improved patient outcomes.
| Advanced Heart Failure Symposium | Time |
| Session 1 Chronic Heart Failure Management | |
| (Moderator) | |
| Registration and Breakfast | 7:00 |
| Welcome and Opening Remarks | 7:50 |
| Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Mind the Gradient - Timothy Gong, MD | 8:00 |
| Infiltration Behind Enemy Lines - Presence, Source and Treatment of Cardiac Amyloid - Parag Kale, MD | 8:25 |
| The Weighty Issue of Obesity in Heart Failure - Melody Sherwood, MD | 8:50 |
| Expert Panel Discussion | 9:15 |
| Break and Exhibits | 9:45 |
| Session 2 New Heart Failure Advances | |
| (Moderator) | |
| The Rice Krispies Model of Cardiac Genetics - Robert Gottlieb, MD | 10:15 |
| Imaging in Heart Failure: A Picture is Worth a Thousand Words - But Which Picture - TBD | 10:40 |
| Valvular Heart Disease in Heart Failure: Addressing the Chicken and the Egg - TBD | 11:05 |
| Expert Panel Discussion | 11:30 |
| Lunch | 12:00 |
| Session 3 Device Therapies | |
| (Moderator) | |
| Stage C2D Heart Failure: Mind the Gap - Shelley Hall, MD | 1:00 |
| OP Devices - TBD | 1:30 |
| Making it Rain: Diuresis and Decongestion in Heart Failure - Chris Hebert, MD | 2:00 |
| AI in HF - Let's chat (GPT) about AI - Shiva Patlolla, MD | 2:20 |
| Break and Exhibits | 2:45 |
| Session 4 Cardiogenic Shock | |
| (Moderator) | |
| Cardiogenic Shock - Cesar Guerrero, MD | 3:15 |
| Advanced Cardiac Therapies: "Are We There Yet?" - Aditi Nayak, MD | 3:45 |
| Expert Panel Discussion | 4:15 |
| Closing Remarks and Adjourn - Dr. Shelley Hall | 4:45 |
The Westin Dallas Galleria
13340 Dallas Parkway
Dallas, TX
75240
United States
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING ACCREDITATION: Baylor Scott & White Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.